Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score:10

VJOncology

Lorenza Rimassa, MD, IRCCS Humanitas Research Hospital, Milan, Italy, explains the basics of cholangiocarcinoma, including the incidence, survival rates,...

Julien Taieb, MD, PhD, European Hospital Georges Pompidou, Paris, France, discusses the importance of identifying which patients with colon...

Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, gives an update on the Phase II MOUNTAINEER trial (NCT03043313), which...

Mashup Score:1

VJOncology

Approximately 40% of patients with cholangiocarcinoma have genetic alterations for which targeted therapies already exist. Arndt Vogel, MD, PhD,...

Mashup Score:1

VJOncology

Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses the challenges of diagnosing bile duct...

Mashup Score:1

VJOncology

Highlights from ESMO WCGIC 2022 - 1 month

Mashup Score:1

Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, discusses some of the highlights from the ESMO WCGIC 2022 congress,...

Mashup Score:1

VJOncology

Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses the therapeutic challenges for patients with...

Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses recent positive trials of immunotherapy plus...

Per Pfeiffer, MD, PhD, Odense University Hospital and University of Southern Denmark, Odense, Denmark, discusses recent research into treatments...

Jonathan Strickler, MD, Duke Cancer Institute, Durham, NC, discusses the key points from his talk at ESMO WCGIC 2022...